Drugs / Biovac OCV-S
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07304284 | Oct 2025 → Dec 2026 expected | — | International Vaccine Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biovac OCV-S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07304284 ↗ |
| Modality | Vaccine | “oral cholera vaccine” NCT07304284 ↗ |
| Route | Oral | “given orally” NCT07304284 ↗ |